Clever Culture Systems

Zurich, Switzerland Founded: 2013 • Age: 13 yrs Acquired By LBT Innovations
Automated microbiology solutions for infectious disease diagnostics are developed.

About Clever Culture Systems

Clever Culture Systems is a company based in Zurich (Switzerland) founded in 2013 was acquired by LBT Innovations in December 2021.. The company has 26 employees as of June 30, 2025. Clever Culture Systems offers products and services including APAS Independence, APAS Modules, and Scientific Library. Clever Culture Systems operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.

  • Headquarter Zurich, Switzerland
  • Employees 26 as on 30 Jun, 2025
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Clever Culture Systems Limited
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $3.61 M (USD)
    334.79
    as on Jun 30, 2025
  • Net Profit
    $1.11 M (USD)
    144.92
    as on Jun 30, 2025
  • EBITDA
    $-627.06 K (USD)
    78.92
    as on Jun 30, 2025
  • Latest Funding Round
  • Investors
  • Employee Count
    26

    as on Jun 30, 2025

  • Acquired by
    LBT Innovations

    (Dec 30, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Clever Culture Systems

Clever Culture Systems is a publicly listed company on the ASX with ticker symbol CC5 in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: ASX · Ticker: CC5 . Sector: Health technology · Australia

Products & Services of Clever Culture Systems

Clever Culture Systems offers a comprehensive portfolio of products and services, including APAS Independence, APAS Modules, and Scientific Library. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

AI device for automated imaging and interpretation of culture plates.

Tools for intelligent automation in microbial growth analysis.

Collection of publications and case studies for microbiology research.

People of Clever Culture Systems
Headcount 10-50
Employee Profiles 2
Employee Profiles
People
Jan den Ouden
European Business development manager
People
Chris Ramsey, PhD
Director of Commercial Operations & Business Development

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Clever Culture Systems

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Clever Culture Systems

Clever Culture Systems has secured backing from 1 investor. Prominent investors backing the company include LBT Innovations. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Developer of AI-based automated solutions for the preparation and analysis of microbiology culture specimens
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Clever Culture Systems

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Clever Culture Systems

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Clever Culture Systems Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Clever Culture Systems

Clever Culture Systems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of diagnostic solutions for systemic infections
domain founded_year HQ Location
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
domain founded_year HQ Location
Provider of machine learning based diagnostic solutions for infectious diseases
domain founded_year HQ Location
Portable PCR diagnostics for infectious diseases are developed.
domain founded_year HQ Location
Instruments and test panels for multiplexed molecular diagnostics are provided.
domain founded_year HQ Location
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Clever Culture Systems

When was Clever Culture Systems founded?

Clever Culture Systems was founded in 2013.

Where is Clever Culture Systems located?

Clever Culture Systems is headquartered in Zurich, Switzerland.

How many employees does Clever Culture Systems have?

As of Jun 30, 2025, the latest employee count at Clever Culture Systems is 26.

What is the annual revenue of Clever Culture Systems?

Annual revenue of Clever Culture Systems is $3.61M as on Jun 30, 2025.

What does Clever Culture Systems do?

Clever Culture Systems develops automated clinical microbiology solutions for infectious disease diagnostics. Its proprietary system the Automated Plate Assessment System, or APAS, enables automated screening of microbial culture plates. Its algorithm screens, interprets and sorts plates faster than manual observation. In Oct 2016, the USFDA approved APAS as a Class II medical device.

Who are the top competitors of Clever Culture Systems?

Clever Culture Systems's top competitors include Visby Medical, Inflammatix and MeMed.

What products or services does Clever Culture Systems offer?

Clever Culture Systems offers APAS Independence, APAS Modules, and Scientific Library.

Is Clever Culture Systems publicly traded?

Yes, Clever Culture Systems is publicly traded on ASX under the ticker symbol CC5.

Who are Clever Culture Systems's investors?

Clever Culture Systems has 1 investor. Key investors include LBT Innovations.

What is Clever Culture Systems's ticker symbol?

The ticker symbol of Clever Culture Systems is CC5 on ASX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available